Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5087237
Max Phase: Preclinical
Molecular Formula: C45H74N12O10
Molecular Weight: 943.16
Molecule Type: Unknown
Associated Items:
ID: ALA5087237
Max Phase: Preclinical
Molecular Formula: C45H74N12O10
Molecular Weight: 943.16
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
Standard InChI: InChI=1S/C45H74N12O10/c1-25(2)23-33(39(61)50-28(6)38(60)56-36(26(3)4)42(64)51-27(5)37(59)54-32(44(66)67)18-13-21-49-45(47)48)55-41(63)35-19-14-22-57(35)43(65)31(17-11-12-20-46)53-40(62)34(52-29(7)58)24-30-15-9-8-10-16-30/h8-10,15-16,25-28,31-36H,11-14,17-24,46H2,1-7H3,(H,50,61)(H,51,64)(H,52,58)(H,53,62)(H,54,59)(H,55,63)(H,56,60)(H,66,67)(H4,47,48,49)/t27-,28+,31+,32+,33+,34+,35+,36+/m1/s1
Standard InChI Key: SSKZFTPQIDXAEU-MGFKLGSVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 943.16 | Molecular Weight (Monoisotopic): 942.5651 | AlogP: -1.15 | #Rotatable Bonds: 28 |
Polar Surface Area: 349.23 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.85 | CX Basic pKa: 11.55 | CX LogP: -3.27 | CX LogD: -5.74 |
Aromatic Rings: 1 | Heavy Atoms: 67 | QED Weighted: 0.03 | Np Likeness Score: 0.02 |
1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ.. (2021) Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity., 64 (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174] |
Source(1):